Factors affecting SP-A-mediated phagocytosis in human monocytic cell lines.

Respir Med

Department of Cellular Physiology, Pennsylvania State College of Medicine, P.O. Box 850, Hershey, PA 17033, USA.

Published: July 2004

Surfactant protein-A enhances the phagocytosis and killing of many pathogens, although studying this effect in an assortment of models and different experimental protocols has sometimes yielded conflicting results. In this report, using the human THP-1 cell line as the primary phagocytic cell, we systematically examined several models where microspheres, Staphylococcus aureus and Escherichia coli were used for targets. We found that SP-A derived from human lavage appeared to enhance phagocytosis by two different mechanisms; by SP-A binding of the target to enhance its recognition and subsequent phagocytosis and by a direct SP-A stimulatory effect on the phagocyte itself. Both SP-A mechanisms occurred with different targets in the same experimental system and the SP-A effects were qualitatively (but not quantitatively) comparable in several human cell lines (THP-1, U937, Mono-Mac-6). We also found that the SP-A effects were abrogated when SP-A was combined with surfactant lipids, but the lipids did not affect the basal level of phagocytosis or phagocytosis by mechanisms not involving SP-A. Moreover, the stimulatory effect of SP-A was pH-dependent and appeared to be independent of several other phagocytic mechanisms, including those mediated by Fc receptors and mannose receptor.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmed.2003.12.018DOI Listing

Publication Analysis

Top Keywords

sp-a
9
cell lines
8
phagocytosis mechanisms
8
sp-a stimulatory
8
sp-a effects
8
phagocytosis
6
factors sp-a-mediated
4
sp-a-mediated phagocytosis
4
human
4
phagocytosis human
4

Similar Publications

This study reports the first documented accumulation of lyngbyatoxin-a (LTA), a cyanotoxin produced by marine benthic cyanobacteria, in edible shellfish in Aotearoa New Zealand. The study investigates two bloom events in 2022 and 2023 on Waiheke Island, where hundreds of tonnes of marine benthic cyanobacterial mats (mBCMs) washed ashore each summer. Genetic analysis identified the cyanobacterium responsible for the blooms as sp.

View Article and Find Full Text PDF

Quorum quenching effects of linoleic and stearic acids on outer membrane vesicle-mediated virulence in .

Biofouling

December 2024

Department of Integrative Biology, School of Biosciences and Technology, Vellore Institute of Technology, Katpadi, Vellore, India.

is a pathogenic bacterium that can infect humans and animals, yet the role of its outer membrane vesicles (OMVs) in mediating pathogenicity remains underexplored. This study evaluated the effects of linoleic acid (LA) and stearic acid (SA) on quorum sensing (QS)-mediated violacein production, biofilm formation, and OMV biogenesis in . Our findings revealed that 2 mM LA and 1 mM SA effectively quench QS, leading to a significant reduction in violacein production, biofilm formation, and OMV biogenesis.

View Article and Find Full Text PDF

This study presents an innovative, eco-friendly approach to water treatment through the development of cryogels infused with bioactive Scenedesmus algal extract (ScAE) within a chitosan/poly(vinyl alcohol) (Cs/PVA) matrix. Scenedesmus sp., a green microalga known for its bioactive properties, was cultivated and processed to obtain extracts with coagulation potential.

View Article and Find Full Text PDF

Background: Surfactant protein-A (SP-A) is the most prevalent protein in the pulmonary surfactant system and it is expressed in Type II alveolar epithelial cells.

Materials And Methods: We evaluated SP-A expression in 92 fetal human lungs at various gestational ages in Myanmar (Burma) using hematoxylin and eosin staining and immunohistochemical assays.

Results: We detected tubular structures in the fetal lungs during the canalicular stage of development at gestational weeks 22-25.

View Article and Find Full Text PDF

Surfactant Protein-A (SP-A) and its Immunomodulatory Roles in Infant Respiratory Syncytial Virus (RSV) Infection - a potential for therapeutic intervention?

Am J Physiol Lung Cell Mol Physiol

December 2024

Targeted Lung Immunotherapy Group, Neonatology Department, Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, United Kingdom.

The vast majority of early-life hospital admissions globally highlight Respiratory Syncytial Virus (RSV), the leading cause of neonatal lower respiratory tract infections, as the major culprit behind the poor neonatal outcomes following respiratory infections. Unlike those of older children and adults, the immune system of neonates looks rather unique, therefore mostly counting on the innate immune system and antibodies of maternal origins. The collaborations between cells and immune compartments during infancy inclines to bias toward a T-helper 2 (Th2) immune profile and thereby away from a T-helper 1 (Th1) immune response.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!